Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Revision Shoulder Arthroplasty
NCT04650698Phase 4Terminated
- Sponsor
- NYU Langone Health
- Start
- Jan 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tranexamic acid in arthropathy (2 arms), sponsored by NYU Langone Health. Primary endpoints: Total Calculated Total Blood Loss and Total Surgical Drain Output. Started Jan 2021; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
arthropathy
Beyond the preview
Go deeper on NCT04650698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650698.